Researchers were awarded approximately $3 million from the National Institutes of Health to continue studying how our bodies respond to seasonal and pandemic flu viruses and vaccines.
Rochester scientists are using a gene test to diagnose a difficult-to-detect form of bone marrow cancer – an example of how academic medical centers are applying new technology in ways that play to their strengths to achieve better patient care.
When prostate cancer is detected through a screening test and no symptoms are present, logic would say the disease is probably insignificant and the patient can avoid aggressive treatment. Yet statistics tell a different story: 1 in 6 of these men will have higher-risk disease, according to a University of Rochester study published in Frontiers in Oncology.
Several members of the lymphoma and leukemia teams at the James P. Wilmot Cancer Center are to present research at the 55th annual American Society of Hematology (ASH) meeting, Dec. 7 to 10, which is attended by more than 20,000 clinicians and scientists.
A study in the Annals of Surgery found that smoking boosts the risk of complications like infection and pneumonia after some of the most common colorectal procedures. Author Fergal Fleming, M.D., breaks down the risks in this video.
If you’re being treated for cancer and experiencing symptoms, what would cause you to pick up the phone and call your cancer center? Pain emerged as the number one reason, in a study of 563 patients, who reported 2,378 symptoms during 1,229 phone calls to the James P. Wilmot Cancer Center.
The goal of this blog is to bring more medical research stories to light and provide our readers with timely and engaging coverage of scientific and medical developments here in Rochester and beyond.
April 2014 (4)
March 2014 (8)
February 2014 (11)
January 2014 (6)
December 2013 (10)
November 2013 (5)
October 2013 (8)
September 2013 (7)
August 2013 (12)
July 2013 (12)
June 2013 (14)
May 2013 (2)